MetaCap

PAVmed (PAVM) vs SiNtx Technologies (SINT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

SiNtx Technologies (SINT) has outperformed PAVmed (PAVM) over the past year, losing 65.7% versus a loss of 88.8%. Over five years, PAVM leads with a -99.9% price change compared with -100.0% for SINT. PAVmed is the larger company by market cap ($9.1 million vs $8.3 million), about 1.1 times the size, while SiNtx Technologies is growing revenue faster (-64.7% vs -97.6%).

PAVmed converts more of its revenue into profit, with a net margin of 564.8% versus -1018.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PAVM-88.77%SINT-65.73%
+39%-28%-95%
Nov 21, 20251 yearNov 20, 2026
PAVM-99.94%SINT-99.99%
+5%-50%-105%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PAVM versus SINT key metrics
MetricPAVMSINT
Share price$1.14$1.10
Market cap$9.08M$8.31M
1-day change-5.42%-8.74%
YTD return-82.88%-71.50%
1-year return-88.77%-65.73%
5-year return-99.93%-99.99%
EPS (TTM)$-7.33$-1.54
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$71.00K$1.02M
Revenue growth (YoY)-97.63%-64.74%
Net income (latest FY)$401.00K$-10.36M
Gross margin-207.04%45.28%
Operating margin-30712.68%-1053.14%
Net margin564.79%-1018.07%
52-week high$28.44$4.46
52-week low$1.10$1.09
Distance from 52-week high-96.01%-75.34%
Analyst consensusnonestrong_buy
Avg. price target upside+3115.86%+740.91%
Average volume23.70K48.13K
Shares outstanding8.00M7.56M
Employees4132
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SINT has outperformed PAVM by 23.0 percentage points over the past year.
  • PAVmed is more profitable, keeping 564.8 cents of every revenue dollar as net income versus -1018.1 cents for SiNtx Technologies.
  • SiNtx Technologies grew revenue faster in its latest fiscal year (-64.74% vs -97.63%).

About PAVmed

PAVM stock →

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.

Health Care · Medical/Dental Instruments · 41 employees

About SiNtx Technologies

SINT stock →

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).

Health Care · Medical/Dental Instruments · 32 employees

PAVM vs SINT FAQ

Which is bigger, PAVmed or SiNtx Technologies?

PAVmed (PAVM) is larger, with a market capitalization of $9.08M compared with $8.31M for SiNtx Technologies (SINT).

Which stock has performed better over the past year, PAVM or SINT?

SINT returned -65.73% over the past 12 months, compared with -88.77% for PAVM (price return, excluding dividends). Past performance does not predict future results.

Are PAVmed and SiNtx Technologies in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons